We are attending Evidence Europe at the Victoria Park Plaza in London on the 22-23rd of February. For those of you who have not come across the Evidence series of conferences, they are one of the worlds premier Real-World Evidence conferences featuring many thought leaders from across the industry.
In a recent edition of ‘Trends’ entitled ‘Real-World Evidence Revolution’, Paul Simms (Chairman of eyeforpharma) articulated a thought I have had running through my head for a while now:
“… the health economy is changing fast, moving from measuring inputs (e.g. number of patients seen, pills sold ect.) to outputs (most importantly, patient outcomes).”
A recent publication in ‘Pharmacoepidemiology and Safety’ highlighted how our team of Safety Nurses worked in conjunction with a remote EHR monitoring system to ensure patient safety throughout the Salford Lung Study.
CK Aspire’s Domiciliary Research Team were thrilled to attend the Nursing Times Awards last night at the Grosvenor House Hotel, Park Lane in London.
CK Aspire are pleased to announce they are exhibiting at the upcoming 26th International Congress of the European Respiratory Society in London between 3rd and 7th September at stand C.25.
CK Aspire submitted an entry into the Nursing Times Awards for our Domiciliary Research Team involved in the Salford Lung Study earlier this year. The short list has been announced and it’s fantastic to say that their entry has been shortlisted in the clinical research nursing category.
Salford Lung Study results show COPD patients treated with Relvar® Ellipta® achieve superior reduction in exacerbations compared with ‘usual care’
Pioneering GSK study provides important new data on the effectiveness of Relvar Ellipta (FF/VI) when used in everyday clinical practice
CK Aspire are recruiting for a Clinical Business Development Manager to join our growing team working in the field of Real World Evidence and Clinical Development. This is a permanent role and can be based in Stevenage, Manchester, Chesterfield or potentially field based.
CK Aspire are a leading CRO in the world of pragmatic Real World Evidence studies and have been heavily involved in the highly publicised Salford Lung Study.
On 10th and 11th May CK Aspire will be exhibiting at the Market Access & Real World Evidence event that is being held in Amsterdam.
The event, which attracts over 300 delegates from across Europe, features 50 expert speakers covering highly topical subjects such as: